APO AB 300 (Abacavir Sulfate 300 mg (base))
Pill with imprint APO AB 300 is Yellow, Capsule-shape and has been identified as Abacavir Sulfate 300 mg (base). It is supplied by Apotex Corp.
Abacavir is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Abacavir 300 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO AB 300
Abacavir Sulfate
- Imprint
- APO AB 300
- Strength
- 300 mg (base)
- Color
- Yellow
- Size
- 15.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (nrtis)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp
- Inactive Ingredients
-
silicon dioxide,
magnesium stearate,
microcrystalline cellulose,
hypromelloses,
polyethylene glycol 8000,
ferric oxide yellow,
croscarmellose sodium,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 60505-3583 | Apotex Corp. |
| 00904-6523 | Major Pharmaceuticals |
Related Images for "APO AB 300"
More about abacavir
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- FDA Alerts (3)
Consumer resources
- Other brands
- Ziagen
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.